Literature DB >> 5791483

Cyclophosphamide therapy of peripheral uveitis.

C E Buckley, J P Gills.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5791483

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  10 in total

Review 1.  Immunosuppression in uveitis therapy.

Authors:  R N Van Gelder; H J Kaplan
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Treatment of Behcet's disease with chlorambucil.

Authors:  D Tricoulis
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

3.  Kinetics of the reactive cell clones after immunosuppression and induction of tolerance: (1) inhibition of 19 S and 7 S plaque-forming cells in the primary and secondary immune response to sheep red blood cells by cyclophosphamide and 036.5122 (Asta).

Authors:  U Botzenhardt; E M Lemmel
Journal:  Agents Actions       Date:  1975-12

4.  Immunosuppressive therapy of ocular disease.

Authors:  W B Boone; L Slater
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

5.  Cyclophosphamide and whole organ transplantation in human beings.

Authors:  T E Starzl; C W Putnam; C G Halgrimson; G T Schroter; G Martineau; B Launois; J L Corman; I Penn; A S Booth; C G Groth; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1971-12

6.  Borna disease virus-induced retinouveitis treated with immunosuppressive drugs.

Authors:  H Krey; H Ludwig; M Gierend
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

7.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 8.  The diagnosis and management of uveitis.

Authors:  E Anglade; S M Whitcup
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

9.  Influence of immunosuppressive treatment of Borna Disease in rabbits.

Authors:  M Gierend; H Ludwig
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 10.  Systemic therapies for inflammatory eye disease: past, present and future.

Authors:  Alastair K Denniston; Andrew D Dick
Journal:  BMC Ophthalmol       Date:  2013-04-24       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.